Effectiveness of screening for diabetes mellitus in dental health care

Diabetic Medicine

Volumn 30, Issue 2, 2013, Pages 239-245

  Engstrom S ^a,b,c   Berne, C ^b   Gahnberg, L ^d,e   Svardsudd K ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c Orthodontic Clinic   (Sweden)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

^e Public Dental Service   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ADULT; AGED; ARTICLE; BLOOD GLUCOSE METER; BLOOD GLUCOSE MONITORING; BODY MASS; CLINICAL EFFECTIVENESS; DENTAL PROCEDURE; DIABETES MELLITUS; DIABETIC PATIENT; FOLLOW UP; GENERAL PRACTITIONER; GLUCOSE BLOOD LEVEL; GROUPS BY AGE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIMARY HEALTH CARE; RETROSPECTIVE STUDY; SCREENING TEST; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; BLOOD GLUCOSE; BODY MASS INDEX; DENTAL HEALTH SERVICES; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PRIMARY HEALTH CARE; REFERRAL AND CONSULTATION; SENSITIVITY AND SPECIFICITY; SWEDEN;

EID: 84872741851     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.12009     Document Type: Article

References (28)

1. WHO. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Part1. Geneva: WHO, 1999.
2. Jansson SP, Andersson DK, Svardsudd K. Prevalence and incidence rate of diabetes mellitus in a Swedish community during 30years of follow-up. Diabetologia 2007; 50: 703-710.
3. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-1053.
4. Engelgau MM, Narayan KM, Herman WH. Screening for type2 diabetes. Diabetes Care 2000; 23: 1563-1580.
5. Andersson DK, Lundblad E, Svardsudd K. A model for early diagnosis of Type2 diabetes mellitus in primary health care. Diabet Med 1993; 10: 167-173.
6. UK Prospective Diabetes Study 6. Complications in newly diagnosed type2 diabetic patients and their association with different clinical and biochemical risk factors. Diabetes Res 1990; 13: 1-11.
7. Brohall G, Behre CJ, Hulthe J, Wikstrand J, Fagerberg B. Prevalence of diabetes and impaired glucose tolerance in 64-year-old Swedish women: experiences of using repeated oral glucose tolerance tests. Diabetes Care 2006; 29: 363-367.
8. Engstrom S, Berne C, Gahnberg L, Svardsudd K. Efficacy of screening for high blood pressure in dental health care. BMC Public Health 2011; 11: 194.
9. Dekkers JC, van Wier MF, Hendriksen IJ, Twisk JW, van Mechelen W. Accuracy of self-reported body weight, height and waist circumference in a Dutch overweight working population. BMC Med Res Methodol 2008; 8: 69.
10. WHO. Screening for Type2 Diabetes, Report of a World Health Organization and International Diabetes Federation Meeting. 2003. Available at http://www.who.int/diabetes/publications/en/screening_mnc03.pdf Last accessed 28 February 2012.
11. Rolka DB, Narayan KM, Thompson TJ, Goldman D, Lindenmayer J, Alich K et al. Performance of recommended screening tests for undiagnosed diabetes and dysglycemia. Diabetes Care 2001; 24: 1899-1903.
12. Andersson DK, Petersson C. Motiverat att screena för typ 2-diabetes. (Screening for type2 diabetes is justified). Lakartidningen 1998; 95: 5167-5170, 5175.
13. WHO. International Classification of Diseases. Available at http://www.who.int/classifications/icd/en/index.html Last accessed 28 February 2012.
14. SAS. Statistical Analysis System. 20 February 2004. Available at http://www.sas.com/technologies/analytics/statistics/stat/factsheet.pdf Last accessed 28 February 2012.
15. Waugh N, Scotland G, McNamee P, Gillett M, Brennan A, Goyder E et al. Screening for type2 diabetes: literature review and economic modelling. Health Technol Assess 2007, 11: iii-iv, ix-xi, 1-125.
16. Bandolier. Website. Available at http://www.medicine.ox.ac.uk/bandolier/band59/NNT1.html#Heading5 Last accessed 15 February 2010.
17. Sacket DL, Haynes RB, Guyatt GH, Tugwell P. Clinical Epidemiology: A Basic Science For Clinical Medicine. Boston/Toronto/London: Little Brown and Company, 1991.
18. Klein Woolthuis EP, de Grauw WJ, van Gerwen WH, van denHoogen HJ, van deLisdonk EH, Metsemakers JF et al. Screening for type2 diabetes in primary care using a stepwise protocol: the Diabscreen study. Prim Care Diabetes 2007; 1: 199-202.
19. Socialstyrelsen. Nationella Riktlinjer för Diabetesvården (National Guidelines for Diabetes Care). 2011. Available at http://www.socialstyrelsen.se/nationellariktlinjerfordiabetesvarden/centralarekommendationer Last accessed 28 February 2012.
20. WHO. Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia. 2006. Available at http://www.who.int/diabetes/publications/Definition%20and%20diagnosis%20of%20diabetes_newpdf Last accessed 28 February 2012.
21. Borrell LN, Kunzel C, Lamster I, Lalla E. Diabetes in the dental office: using NHANESIII to estimate the probability of undiagnosed disease. J Periodontal Res 2007; 42: 559-565.
22. Lalla E, Kunzel C, Burkett S, Cheng B, Lamster IB. Identification of unrecognized diabetes and pre-diabetes in a dental setting. J Dent Res 2011; 90: 855-860.
23. Demmer RT, Jacobs DR Jr, Desvarieux M. Periodontal disease and incident type2 diabetes: results from the First National Health and Nutrition Examination Survey and its epidemiologic follow-up study. Diabetes Care 2008; 31: 1373-1379.
24. Zhang P, Engelgau MM, Valdez R, Cadwell B, Benjamin SM, Narayan KM. Efficient cutoff points for three screening tests for detecting undiagnosed diabetes and pre-diabetes: an economic analysis. Diabetes Care 2005; 28: 1321-1325.
25. Klein Woolthuis EP, de Grauw WJ, van Gerwen WH, van den Hoogen HJ, van de Lisdonk EH, Metsemakers JF et al. Yield of opportunistic targeted screening for type2 diabetes in primary care: the diabscreen study. Ann Fam Med 2009; 7: 422-430.
26. Greaves CJ, Stead JW, Hattersley AT, Ewings P, Brown P, Evans PH. A simple pragmatic system for detecting new cases of type2 diabetes and impaired fasting glycaemia in primary care. Fam Pract 2004; 21: 57-62.
27. Toscano CM, Duncan BB, Mengue SS, Polanczyk CA, Nucci LB, Costa e Forti A et al. Initial impact and cost of a nationwide population screening campaign for diabetes in Brazil: a follow up study. BMC Health Serv Res 2008; 8: 189.
28. O'Connor PJ, Rush WA, Cherney LM, Pronk NP. Screening for diabetes mellitus in high-risk patients: cost, yield, and acceptability. Eff Clin Pract 2001; 4: 271-277.